Glucagonoma

An almost always malignant GLUCAGON-secreting tumor derived from the PANCREATIC ALPHA CELLS. It is characterized by a distinctive migratory ERYTHEMA; WEIGHT LOSS; STOMATITIS; GLOSSITIS; DIABETES MELLITUS; hypoaminoacidemia; and normochromic normocytic ANEMIA.

Also Known As:

Glucagonoma Syndrome; Adenoma, alpha Cell; Adenomas, alpha-Cell; Glucagonoma Syndromes; Glucagonomas; Syndrome, Glucagonoma; Syndromes, Glucagonoma; Tumor, alpha-Cell; Tumors, alpha-Cell; alpha Cell Tumor; alpha-Cell Adenoma; alpha-Cell Adenomas; alpha-Cell Tumors; Adenoma, alpha-Cell; alpha-Cell Tumor

Neoplasms: 1324753
- Neoplasms by Site: 4
  - Digestive System Neoplasms: 236
    - Pancreatic Neoplasms: 34238
      - Islet Cell Carcinoma: 160
        Glucagonoma: 430
  - Endocrine Gland Neoplasms: 130
    - Pancreatic Neoplasms: 34238
      - Islet Cell Carcinoma: 160
        Glucagonoma: 430
- Neoplasms by Histologic Type: 2
  - Glandular and Epithelial Neoplasms: 439
    - Carcinoma: 141855
      - Adenocarcinoma: 58365
        Islet Cell Carcinoma: 160
        Glucagonoma: 430
Digestive System Diseases: 1042
- Pancreatic Diseases: 1635
  - Pancreatic Neoplasms: 34238
    - Islet Cell Carcinoma: 160
      - Glucagonoma: 430
- Digestive System Neoplasms: 236
  - Pancreatic Neoplasms: 34238
    - Islet Cell Carcinoma: 160
      - Glucagonoma: 430
Endocrine System Diseases: 968
- Endocrine Gland Neoplasms: 130
  - Pancreatic Neoplasms: 34238
    - Islet Cell Carcinoma: 160
      - Glucagonoma: 430

Isabel Hernández-Jurado Selected Research

Isabel Hernández-Jurado Research Topics

Disease

Drug/Important Bio-Agent (IBA)